The Intravenous Iron Drugs Market is projected to surge in the coming years, according to a recent market survey by FMI. The market, valued at US$2.6 billion in 2021, is expected to reach a staggering US$6.3 billion by 2032, reflecting a significant increase. This growth is largely driven by the rising demand for ferric carboxymaltose, …